Nov 08, 2018 9:00am EST CohBar Co-Founder and Scientific Advisor Dr. David Sinclair Named as one of TIME Magazine’s Health Care 50
Oct 31, 2018 9:00am EDT CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018
Aug 02, 2018 1:09pm EDT CohBar, Inc. to Announce 2018 Second Quarter Financial Results and Host Conference Call for Shareholders on August 14, 2018
Jul 12, 2018 9:00am EDT CohBar Initiates Clinical Study with First-in-human Dosing of CB4211, a Novel Mitochondria Based Therapeutic for the Treatment of NASH
Jun 25, 2018 12:08pm EDT CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions